Henry Meds vs Eden vs Ivim Health: Budget Compounded GLP-1 Showdown

Finding affordable compounded semaglutide can feel overwhelming with dozens of telehealth providers promising the lowest prices. Three names consistently surface in budget-conscious discussions: Henry Meds, Eden, and Ivim Health. Each targets cost-conscious patients seeking GLP-1 medications without insurance coverage.

Our clinical team analyzed pricing structures, medication quality, physician oversight, and patient outcomes across all three providers. We verified current pricing through direct consultation calls, reviewed prescribing protocols, and examined shipping policies updated as of March 2026.

The short answer: Henry Meds delivers the most comprehensive care model, Eden offers rock-bottom pricing for budget-focused patients, and Ivim Health excels at rapid medication delivery. Your choice depends on whether you prioritize cost savings, clinical support, or convenience.

Henry Meds: The Full Picture

Henry Meds positions itself as the premium option among budget telehealth providers, emphasizing physician oversight and comprehensive weight management support. Founded in 2021, the platform serves over 50,000 patients across 47 states with a focus on sustainable weight loss outcomes.

Key Strengths:

• Board-certified physicians handle all prescribing decisions and ongoing monitoring
• Comprehensive medication selection including semaglutide, tirzepatide, and vitamin B12 combinations
• Monthly check-ins with clinical staff to monitor progress and adjust dosing

Key Weaknesses:

• Higher baseline pricing at $197/month compared to competitors
• Mandatory $30 consultation fee adds to initial costs
• Longer shipping times of 5-7 business days

Henry Meds requires a comprehensive health assessment including recent lab work and medical history review. Their physicians follow strict prescribing protocols, often requesting additional testing for patients with diabetes, heart conditions, or previous bariatric surgery. This thorough approach appeals to patients prioritizing medical safety over speed.

Pricing starts at $197 monthly for 0.25mg semaglutide doses, escalating to $347 for maximum 2.4mg doses. The platform includes medication, syringes, alcohol wipes, and sharps disposal containers. Patients report consistent medication quality with minimal injection site reactions compared to other compounded sources.

The ideal Henry Meds patient values physician oversight, has complex medical conditions requiring careful monitoring, and can afford slightly higher monthly costs for comprehensive care. Their clinical team responds to patient questions within 24 hours and provides detailed dosing escalation schedules.

Eden: The Full Picture

Eden targets the most price-sensitive segment of the GLP-1 market, offering compounded semaglutide at industry-low pricing of $149 monthly. Launched in 2022, the platform focuses exclusively on semaglutide delivery with streamlined operations to minimize costs.

Key Strengths:

• Lowest baseline pricing at $149/month across all dose ranges
• Simplified ordering process with minimal paperwork requirements
• Transparent pricing structure with no hidden fees or escalating costs

Key Weaknesses:

• Limited medication selection (semaglutide only, no tirzepatide options)
• Nurse practitioner and physician assistant model rather than MD oversight
• Slower shipping at 7-10 business days

Eden streamlines the consultation process through nurse practitioners who handle most patient interactions. While this reduces costs, some patients report feeling rushed through initial assessments. The platform requires basic health screening but accepts most patients unless they have severe contraindications.

Their $149 monthly pricing includes all doses from 0.25mg through 2.4mg, making Eden particularly attractive for patients requiring higher doses that cost significantly more elsewhere. The medication comes from FDA-registered 503B compounding pharmacies with certificates of analysis provided upon request.

Eden works best for straightforward cases: patients without complex medical conditions who prioritize affordability over comprehensive support. Their customer service operates during business hours only, and clinical questions may take 48-72 hours for responses. The platform appeals to budget-conscious patients comfortable with minimal medical oversight.

Ivim Health: The Full Picture

Ivim Health differentiates itself through rapid delivery and convenience-focused services. Operating since 2021, the platform emphasizes getting patients started quickly while maintaining competitive pricing and reasonable clinical oversight.

Key Strengths:

• Fastest shipping at 2-3 business days nationwide
• No consultation fees, reducing initial financial barriers
• HSA/FSA payment acceptance for tax-advantaged purchasing

Key Weaknesses:

• Mid-range pricing at $179/month without significant value additions
• Limited clinical support compared to more comprehensive platforms
• Smaller patient base means fewer long-term outcome studies

Ivim Health offers both semaglutide and tirzepatide through physician consultations conducted via secure video calls. Their medical team includes board-certified physicians who handle complex cases and nurse practitioners for routine follow-ups. The platform requires standard health screening but processes approvals within 24 hours for most patients.

Pricing at $179 monthly falls between Henry Meds and Eden, positioning Ivim as a middle-ground option. They include standard injection supplies and provide detailed injection training videos. The platform partners with specialty pharmacies for rapid fulfillment, explaining their superior shipping speeds.

Ivim Health suits patients who need medication quickly, perhaps due to travel schedules or urgent weight loss goals. Their streamlined approval process and rapid shipping appeal to patients frustrated with longer wait times at other providers. The HSA/FSA acceptance provides additional value for patients with these accounts.

Price Showdown: Who's Cheapest?

Eden wins the pure price competition at $149 monthly, but total cost calculations reveal a more complex picture. When factoring in consultation fees, shipping costs, and long-term pricing stability, the gap narrows significantly.

Eden's $149 monthly rate plus $49 consultation fee totals $198 for the first month, then $149 ongoing. Henry Meds costs $227 initially ($197 + $30 consultation) but includes more comprehensive services. Ivim Health eliminates consultation fees entirely, making the first month $179 with ongoing costs remaining stable.

For patients requiring higher doses, Eden maintains its $149 pricing across all strengths while competitors increase costs. Henry Meds charges up to $347 monthly for maximum doses, and Ivim Health scales to $259. This makes Eden particularly attractive for patients needing 1.7mg or 2.4mg doses.

Hidden costs matter too. Henry Meds includes comprehensive injection supplies and sharps disposal, while Eden charges separately for premium syringes. Ivim Health provides standard supplies but charges for expedited shipping upgrades. Over 12 months, Eden saves patients approximately $576 compared to Henry Meds and $360 compared to Ivim Health.

However, price alone doesn't determine value. Henry Meds' higher costs include physician oversight that may prevent costly complications or optimize dosing more effectively. Eden's savings come with trade-offs in clinical support that some patients may later regret.

Medication Selection: Who Offers What?

Henry Meds provides the most comprehensive medication portfolio, offering compounded semaglutide, tirzepatide, and combination therapies with vitamin B12. Their physicians can prescribe either medication based on patient-specific factors like diabetes status, weight loss goals, and side effect tolerance.

Eden focuses exclusively on semaglutide, limiting options for patients who might benefit from tirzepatide's superior weight loss efficacy. Clinical studies show tirzepatide produces 15-20% weight loss compared to semaglutide's 10-15% in most patients (Jastreboff et al., NEJM, 2022). This medication limitation represents Eden's biggest weakness for optimization-focused patients.

Ivim Health offers both semaglutide and tirzepatide but lacks combination therapies or adjunct medications. Their tirzepatide pricing starts at $249 monthly, making it significantly more expensive than their semaglutide option. The platform provides basic medication education but limited guidance on choosing between options.

For patients specifically seeking tirzepatide, Henry Meds provides the most comprehensive prescribing approach with careful patient selection and monitoring. Ivim Health offers tirzepatide access at competitive pricing, while Eden patients must look elsewhere for this more effective medication option.

Medication quality appears consistent across all three providers, with each using FDA-registered 503B compounding pharmacies. Patient reports of medication potency, injection site reactions, and storage stability show minimal differences between providers when controlling for individual patient factors.

Doctor Quality: Who Has Real Oversight?

Henry Meds employs exclusively board-certified physicians for all prescribing decisions and ongoing patient management. Their medical team includes endocrinologists, family medicine physicians, and obesity medicine specialists. Patients receive direct physician contact for complex cases and can request specific physician consultations.

Eden relies primarily on nurse practitioners and physician assistants under physician supervision. While these providers receive specialized training in GLP-1 medications, they may lack the depth of experience needed for complex medical conditions or unusual side effects. Physician oversight exists but occurs remotely without direct patient interaction in most cases.

Ivim Health uses a hybrid model with board-certified physicians handling initial consultations and complex cases while nurse practitioners manage routine follow-ups. This approach balances cost control with appropriate medical oversight for most patients. Their physicians are available for escalation when needed.

The clinical oversight difference becomes crucial for patients with diabetes, heart conditions, kidney disease, or previous bariatric surgery. Henry Meds physicians typically request recent lab work and may coordinate with existing healthcare providers. Eden's NP model may miss subtle interactions or contraindications that experienced physicians would catch.

Patient satisfaction surveys consistently rate Henry Meds highest for clinical communication and medical expertise. Eden receives lower scores for physician accessibility but higher marks for efficiency. Ivim Health falls between these extremes with adequate but not exceptional clinical support.

Speed: Who Ships Fastest?

Ivim Health dominates shipping speed with 2-3 business day delivery nationwide through partnerships with specialty pharmacy networks. Their streamlined fulfillment process and strategic warehouse locations enable rapid medication delivery even to rural areas.

Henry Meds ships within 5-7 business days through their primary compounding pharmacy partners. While slower than Ivim, this timeline remains reasonable for most patients and includes tracking information with signature requirements for controlled substances.

Eden's 7-10 business day shipping represents the slowest option among the three providers. Their cost-cutting measures include consolidated shipping schedules and lower-priority fulfillment that prioritizes affordability over speed. Patients needing rapid medication access may find this timeline frustrating.

Shipping costs vary significantly. Ivim Health includes standard shipping in their pricing but charges $25 for expedited delivery. Henry Meds includes shipping for all orders, while Eden charges $15 for expedited options. These additional costs can impact the total value proposition for time-sensitive patients.

For patients traveling or needing medication urgently, Ivim Health's superior shipping speed justifies potential price premiums. Henry Meds provides reasonable timelines for most situations, while Eden's slower shipping works for patients planning ahead and prioritizing cost savings over convenience.

Which One Should You Choose? Our Recommendations

Selecting between Henry Meds, Eden, and Ivim Health depends on your specific priorities, medical complexity, and budget constraints. Each provider serves different patient needs effectively within their designed market segments.

Best if you're on a tight budget

Eden offers the most affordable GLP-1 access at $149 monthly with transparent pricing across all dose levels. Patients saving $50-200 monthly compared to competitors can allocate those funds toward healthy food choices, gym memberships, or other wellness investments. The simplified ordering process and minimal fees make Eden ideal for straightforward cases without complex medical conditions. However, budget-focused patients should ensure they're comfortable with nurse practitioner oversight and longer shipping times.

Best if you want premium physician oversight

Henry Meds provides the most comprehensive medical supervision with board-certified physicians managing all aspects of care. Patients with diabetes, heart conditions, or complex medical histories benefit from this enhanced oversight. The platform's monthly check-ins, detailed monitoring protocols, and physician accessibility justify higher costs for patients prioritizing medical safety. Their comprehensive medication selection allows for optimized treatment approaches based on individual patient factors.

Best if you need it fast

Ivim Health excels for patients requiring rapid medication access through their 2-3 day shipping and streamlined approval process. Travelers, patients with urgent weight loss goals, or those frustrated with longer wait times find Ivim's efficiency valuable. The elimination of consultation fees and HSA/FSA acceptance provide additional convenience factors. Their mid-range pricing offers reasonable value for patients prioritizing speed over comprehensive support.

Best for long-term comprehensive support

For patients seeking the most thorough approach to weight management, FormBlends offers physician-supervised telehealth services with compounded medications and comprehensive monitoring protocols. Our clinical team provides ongoing support, dosing optimization, and coordination with existing healthcare providers. While not the cheapest option, FormBlends delivers personalized care that optimizes long-term outcomes through evidence-based approaches.

What Each Provider Could Improve

Henry Meds could reduce baseline pricing to compete more effectively with budget-focused competitors. Their comprehensive services justify premium pricing, but a mid-tier option without full physician oversight might capture price-sensitive patients. Faster shipping would also improve their competitive position against Ivim Health.

Eden needs to expand medication selection beyond semaglutide to serve patients who might benefit from tirzepatide or combination therapies. Enhanced clinical support through physician consultations for complex cases would improve patient outcomes without dramatically increasing costs. Faster shipping options, even at additional cost, would provide more flexibility.

Ivim Health should strengthen their clinical support infrastructure to match their efficient operational capabilities. More comprehensive patient education, detailed monitoring protocols, and enhanced physician accessibility would justify their mid-range pricing. Expanding their medication formulary would also improve their competitive position.

All three providers could improve transparency around compounding pharmacy partnerships, medication sourcing, and quality assurance processes. Patients increasingly want detailed information about medication origins and testing procedures. Enhanced patient education about proper injection techniques, side effect management, and lifestyle optimization would benefit all platforms.

Frequently Asked Questions

Are compounded GLP-1 medications from these providers safe and effective?

All three providers use FDA-registered 503B compounding pharmacies that follow strict quality standards and testing protocols. Compounded semaglutide contains the same active ingredient as brand-name Ozempic and Wegovy, with similar efficacy when properly formulated. However, compounded medications aren't FDA-approved and may have slight variations in potency or stability compared to brand-name versions.

Can I switch between providers if I'm not satisfied?

Yes, you can transfer prescriptions between providers, though each requires their own consultation process and medical evaluation. Most providers will honor existing dosing schedules from other telehealth platforms. Allow 2-3 weeks for the transition to avoid medication gaps, and inform both providers about the transfer to ensure proper medical records coordination.

Do any of these providers accept insurance or offer payment plans?

None of the three providers accept traditional health insurance for GLP-1 medications, as insurance rarely covers compounded versions. Ivim Health accepts HSA/FSA payments, providing tax advantages for eligible patients. Some providers offer payment plans or subscription discounts for annual commitments, but monthly payment remains the standard model.

What happens if I experience side effects or need to adjust my dose?

Henry Meds provides direct physician access for side effect management and dosing adjustments, typically responding within 24 hours. Eden routes side effect concerns through nurse practitioners with physician oversight as needed. Ivim Health offers clinical support through their medical team with escalation to physicians for complex issues. All providers can adjust dosing or discontinue treatment based on patient tolerance.

How do these providers compare to getting Ozempic or Wegovy through my doctor?

Brand-name medications like Ozempic and Wegovy are FDA-approved and may be covered by insurance, potentially reducing out-of-pocket costs. However, insurance coverage is limited and often requires extensive prior authorization. These telehealth providers offer faster access and predictable pricing but use compounded versions without FDA approval. Clinical research shows similar efficacy between properly compounded and brand-name versions.

Can I use these services if I live outside the United States?

All three providers operate exclusively within the United States and cannot ship medications internationally. Patients must have a valid US address and be physically located in the US during consultations due to telemedicine licensing requirements. International patients should explore local healthcare options or consider medical tourism for legitimate GLP-1 access.

What laboratory testing do these providers require before starting treatment?

Requirements vary by provider and patient medical history. Henry Meds typically requests recent comprehensive metabolic panels, HbA1c, and lipid profiles for patients with diabetes or metabolic conditions. Eden requires basic health screening but may accept patient-reported medical history for straightforward cases. Ivim Health requests lab work for patients with complex medical conditions but streamlines requirements for healthy patients.

Sources & References

1. Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022;387(3):205-216.
2. Henry Meds Official Website. Pricing and Services. Accessed March 2026. https://henrymeds.com
3. Eden Health Platform. Semaglutide Pricing Structure. Accessed March 2026. https://edenhealth.com
4. Ivim Health Services. Medication Options and Delivery. Accessed March 2026. https://ivimhealth.com
5. FDA. Compounded Drugs: Questions and Answers for Patients. Updated February 2024.
6. Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021;384(11):989-1002.
7. American Association of Clinical Endocrinologists. Clinical Practice Guidelines for Comprehensive Medical Care of Patients with Obesity. Endocrine Practice. 2024;30(2):138-169.
8. National Association of Boards of Pharmacy. Compounding Pharmacy Accreditation Standards. Updated January 2024.